|
Originally published In Press as doi:10.1074/jbc.M211930200 on December 24, 2002
J. Biol. Chem., Vol. 278, Issue 11, 9560-9569, March 14, 2003
Localization of the Discontinuous Immunodominant Region
Recognized by Human Anti-thyroperoxidase Autoantibodies in
Autoimmune Thyroid Diseases*
Damien
Bresson §,
Martine
Cerutti¶,
Gérard
Devauchelle¶,
Martine
Pugnière ,
Françoise
Roquet ,
Cédric
Bès ,
Carine
Bossard** ,
Thierry
Chardès¶, and
Sylvie
Péraldi-Roux
From the CNRS Unité Mixte de Recherche
(UMR) 5094, Faculté de Pharmacie, 15 avenue Charles
Flahault, B. P. 14491, Montpellier 34093 Cedex 5, ¶ CNRS-Institut National de la Recherche Agronomique UMR 5087,
Station de Recherche de Pathologie Comparée, St.
Christol-lez-Alès 30380, and ** INSERM U397, Institut
Fédératif de Recherche Louis Bugnard, Centre Hospitalier
Universitaire Rangueil, Toulouse 31403 Cedex 4, France
The discontinuous immunodominant region
(IDR) recognized by autoantibodies directed against the thyroperoxidase
(TPO) molecule, a major autoantigen in autoimmune thyroid diseases, has
not yet been completely localized. By using peptide phage-displayed
technology, we identified three critical motifs,
LXPEXD, QSYP, and EX(E/D)PPV, within selected mimotopes which interacted with the human recombinant anti-TPO autoantibody (aAb) T13, derived from an antibody
phage-displayed library obtained from thyroid-infiltrating TPO-selected
B cells of Graves' disease patients. Mimotope sequence alignment on
the TPO molecule, together with the binding analysis of the T13 aAb on
TPO mutants expressed by Chinese hamster ovary cells, demonstrated that
regions 353-363, 377-386, and 713-720 from the myeloperoxidase-like domain and region 766-775 from the complement control protein-like domain are a part of the IDR recognized by the recombinant aAb T13.
Furthermore, we demonstrated that these regions were involved in the
binding to TPO of sera containing TPO-specific autoantibodies from
patients suffering from Hashimoto's and Graves' autoimmune diseases.
Identification of the IDR could lead to improved diagnosis of thyroid
autoimmune diseases by engineering "mini-TPO" as a target
autoantigen or designing therapeutic peptides able to block undesired
autoimmune responses.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Recipient of a fellowship from the CNRS and the Région
Languedoc-Roussillon. To whom correspondence should be
addressed. Tel.: 33-467-548-609; Fax: 33-467-548-610; E-mail:
damienbresson@yahoo.fr.
Supported by the Agence National de Recherche contre le Sida.

Supported by the Association pour la Recherche contre le Cancer.
Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Lionaki, S. L. Hogan, R. J. Falk, M. S. Joy, H. Chin, C. E. Jennette, J. C. Jennette, and P. H. Nachman
Association between thyroid disease and its treatment with ANCA small-vessel vasculitis: a case control study
Nephrol. Dial. Transplant.,
December 1, 2007;
22(12):
3508 - 3515.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Dubska, J. P. Banga, D. Plochocka, G. Hoser, E. H. Kemp, B. J. Sutton, A. Gardas, and M. Gora
Structural Insights into Autoreactive Determinants in Thyroid Peroxidase Composed of Discontinuous and Multiple Key Contact Amino Acid Residues Contributing to Epitopes Recognized by Patients' Autoantibodies
Endocrinology,
December 1, 2006;
147(12):
5995 - 6003.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Rebuffat, D. Bresson, B. Nguyen, and S. Peraldi-Roux
The key residues in the immunodominant region 353-363 of human thyroid peroxidase were identified
Int. Immunol.,
July 1, 2006;
18(7):
1091 - 1099.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. P. Ng and A. W. C. Kung
Induction of Autoimmune Thyroiditis and Hypothyroidism by Immunization of Immunoactive T Cell Epitope of Thyroid Peroxidase
Endocrinology,
June 1, 2006;
147(6):
3085 - 3092.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Bresson, S. A. Rebuffat, B. Nguyen, J. P. Banga, A. Gardas, and S. Peraldi-Roux
New Insights into the Conformational Dominant Epitopes on Thyroid Peroxidase Recognized by Human Autoantibodies
Endocrinology,
June 1, 2005;
146(6):
2834 - 2844.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Bresson, M. Pugniere, F. Roquet, S. A. Rebuffat, B. N-Guyen, M. Cerutti, J. Guo, S. M. McLachlan, B. Rapoport, V. Estienne, et al.
Directed Mutagenesis in Region 713-720 of Human Thyroperoxidase Assigns 713KFPED717 Residues as Being Involved in the B Domain of the Discontinuous Immunodominant Region Recognized by Human Autoantibodies
J. Biol. Chem.,
September 10, 2004;
279(37):
39058 - 39067.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|